A promiscuous kinase inhibitor reveals secrets to cancer cell survival

Paul Shapiro1

  • 1Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201.

Insights

Identifying key cancer-driving kinases is challenging due to tumor complexity. A novel nongenetic strategy using a multitargeted kinase inhibitor helps pinpoint critical kinases for cancer cell proliferation, aiding therapeutic development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Kinase signaling pathways are crucial for cancer cell growth and survival.
  • Cancer cells exhibit genetic complexity and rapid evolution, complicating targeted therapy.
  • Identifying specific kinases driving cancer proliferation is essential for effective treatment.

Purpose of the Study:

  • To develop a nongenetic strategy for identifying key kinases in cancer cell proliferation.
  • To leverage a multitargeted kinase inhibitor to overcome challenges in kinase identification.
  • To provide a method for pinpointing kinases essential for specific cancer cell types.

Main Methods:

  • Utilized a well-characterized multitargeted kinase inhibitor.
  • Employed a nongenetic approach to assess kinase roles.
  • Focused on identifying kinases promoting proliferation in distinct cancer cell types.

Main Results:

  • Successfully demonstrated a nongenetic method for kinase identification.
  • The strategy effectively distinguished key kinases driving proliferation.
  • Provided insights into kinase dependencies in specific cancer contexts.

Conclusions:

  • A novel nongenetic strategy can effectively identify critical kinases in cancer.
  • This approach aids in understanding kinase-driven cancer cell proliferation.
  • The method offers a promising avenue for developing targeted cancer therapies.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
658
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.0K
Cells and Secretions of the Pancreas01:16

Cells and Secretions of the Pancreas

The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
4.7K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
481
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Survival Tree01:19

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
410